Evaluating the National Action Plan (NAP) on antimicrobial resistance, and recommendations for the next 5-year NAP: a

Daisy Neale1, Lucky Cullen2

  • 1Policy and Diversity Officer, Applied Microbiology International, Cambridge, CB1 2LA, United Kingdom.

Sustainable Microbiology
|August 11, 2026
PubMed

Insights

The UK

Area of Science:

  • Microbiology and Public Health
  • One Health Approach

Background:

  • The UK's 2019-2024 National Action Plan (NAP) on antimicrobial resistance (AMR) is concluding.
  • A new 5-year NAP is under development, necessitating an analysis of progress and future strategies.
  • An addendum to the current NAP includes revised commitments for AMR containment.

Purpose of the Study:

  • To analyze progress on the UK's National Action Plan (NAP) for antimicrobial resistance (AMR).
  • To gather expert recommendations for the upcoming 5-year NAP.
  • To identify key challenges and considerations for effective AMR policy.

Main Methods:

  • Convened a roundtable discussion with UK human and animal health sector experts in November 2022.
  • Facilitated discussion on progress, recommendations, and future considerations for AMR action plans.
  • Analyzed expert feedback to identify barriers and priorities.

Main Results:

  • A significant gap exists between the rising ambitions of the NAP and diminishing financial support.
  • Challenges include translating evidence into practical, real-world implementation.
  • Lack of communication and funding are primary barriers to achieving NAP commitments.

Conclusions:

  • Prioritize the successful implementation of current NAP commitments before setting future goals.
  • Address funding shortfalls and improve communication to overcome AMR containment barriers.
  • Policymakers must consider these critical areas for effective AMR strategies.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...